Details of patients with Hepatocellular cancer in various centre
Not Applicable
- Conditions
- Health Condition 1: null- Hepatocellular cancerHealth Condition 2: C220- Liver cell carcinoma
- Registration Number
- CTRI/2018/03/012578
- Lead Sponsor
- Tata Memorial Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All patients with a diagnosis of hepatocellular carcinoma.
-HCC will be diagnosed according to Modified European Association for study of Liver (EASL) criteria which includes either biopsy or any two of the following three:
a. AFP >300 ng/dl
b. Arterial enhancement and venous phase washout on CECT
c. Arterial enhancement and venous phase washout on MRI.
Staging of HCC will be done according to Barcelona Clinic Liver Cancer (BCLC) classification.
Exclusion Criteria
Other space occupying lesions in liver like metastasis or primary benign tumors will be excluded from the study
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To analyze the demographic characteristics, clinical presentation, etiological profile and tumour characteristics of patients of HCC presenting to any of the three tertiary care institutions in MumbaiTimepoint: 24 months
- Secondary Outcome Measures
Name Time Method Demographic profile <br/ ><br>Clinical presentation <br/ ><br>Etiology <br/ ><br>Timepoint: 24 months